Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid immunization schedule with FSME-IMMUN 0.25 ml JUNIOR in children
2007-000810-35Phase 4Completed
- Sponsor
- Biovomed
- Start
- Mar 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tick-borne encephalitis vaccine (inactivated) in tick-borne encephalitis (TBE), sponsored by Biovomed. Primary endpoints: Seropositivity rate by ELISA at day 21 after second vaccination, Seropositivity rate by neutralization test at day 21 after second vaccination and 1 more. Started Mar 2007; status: completed.
02
Drugs
tick-borne encephalitis vaccine (inactivated)
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2007-000810-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000810-35.